AVITA Medical, Inc. (RCEL)
9.92
-0.14
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
9.92
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 51.14 |
| March 27, 2025 | 54.01 |
| March 26, 2025 | 52.72 |
| March 25, 2025 | 54.95 |
| March 24, 2025 | 54.60 |
| March 21, 2025 | 52.49 |
| March 20, 2025 | 54.36 |
| March 19, 2025 | 56.88 |
| March 18, 2025 | 54.19 |
| March 17, 2025 | 52.90 |
| March 14, 2025 | 50.08 |
| March 13, 2025 | 48.68 |
| March 12, 2025 | 52.60 |
| March 11, 2025 | 49.03 |
| March 10, 2025 | 48.74 |
| March 07, 2025 | 48.62 |
| March 06, 2025 | 48.44 |
| March 05, 2025 | 49.91 |
| March 04, 2025 | 51.32 |
| March 03, 2025 | 51.14 |
| February 28, 2025 | 53.31 |
| February 27, 2025 | 52.14 |
| February 26, 2025 | 56.35 |
| February 25, 2025 | 55.59 |
| February 24, 2025 | 55.12 |
| Date | Value |
|---|---|
| February 21, 2025 | 57.11 |
| February 20, 2025 | 58.29 |
| February 19, 2025 | 59.87 |
| February 18, 2025 | 60.57 |
| February 14, 2025 | 61.92 |
| February 13, 2025 | 51.43 |
| February 12, 2025 | 50.44 |
| February 11, 2025 | 50.96 |
| February 10, 2025 | 51.55 |
| February 07, 2025 | 50.85 |
| February 06, 2025 | 53.54 |
| February 05, 2025 | 55.30 |
| February 04, 2025 | 53.66 |
| February 03, 2025 | 51.96 |
| January 31, 2025 | 53.31 |
| January 30, 2025 | 55.47 |
| January 29, 2025 | 55.06 |
| January 28, 2025 | 55.83 |
| January 27, 2025 | 54.60 |
| January 24, 2025 | 54.60 |
| January 23, 2025 | 52.43 |
| January 22, 2025 | 49.67 |
| January 21, 2025 | 51.14 |
| January 17, 2025 | 50.67 |
| January 16, 2025 | 50.03 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Halozyme Therapeutics, Inc. | 86.31 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.53 |
| Anika Therapeutics, Inc. | 2.077 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.937 |
| Price | 9.92 |
| Earnings Yield | -14.55% |
| Market Cap | 306.79M |